Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current


Recap: Enanta Pharma Q4 Earnings

Author: Benzinga Insights | November 20, 2023 04:15pm

Enanta Pharma (NASDAQ:ENTA) reported its Q4 earnings results on Monday, November 20, 2023 at 04:01 PM.

Here's what investors need to know about the announcement.


Enanta Pharma beat estimated earnings by 33.5%, reporting an EPS of $-1.33 versus an estimate of $-2.0.

Revenue was down $1.39 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.47 which was followed by a 4.24% drop in the share price the next day.

Here's a look at Enanta Pharma's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -2.33 -1.98 -1.59 -1.35
EPS Actual -1.86 -1.79 -1.39 -1.27
Revenue Estimate 18.06M 19.18M 22.57M 22.86M
Revenue Actual 18.89M 17.80M 23.59M 20.32M

To track all earnings releases for Enanta Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ENTA